Veterinary Dermatology Drugs Market Size
Veterinary Dermatology Medication References With a CAGR of 9.5%, from 2023 to 2032, market size was evaluated to be USD 7.3 billion in 2022 and is predicted to reach USD 18.1 billion. Projected to fuel market expansion are the increased frequency of skin diseases in animals, growing medicalization rate, and higher animal healthcare expenditure.
To get key market trends
Growing demand for veterinary medications, particularly dermatological treatments, results from the worldwide increasing trend of pet ownership. Pets have widespread skin problems; the frequency of dermatological disorders including allergies, infections, and parasitic infestations has been rising. An increasing demand for dermatology medications for different skin conditions results from more people considering their pets as family members being ready to invest in their well-being and healthcare.
| Report Attribute | Details |
|---|---|
| Base Year | 2022 |
| Veterinary Dermatology Drugs Market Size in 2022 | USD 7.3 Billion |
| Forecast Period | 2023 to 2032 |
| Forecast Period 2023 to 2032 CAGR | 9.5% |
| 2032 Value Projection | USD 18.1 Billion |
| Historical Data for | 2018 to 2022 |
| No. of Pages | 248 |
| Tables, Charts & Figures | 431 |
| Segments covered | Drug class, Indication, Route of Administration, Animal Type, Distribution Channel, and Region |
| Growth Drivers |
|
| Pitfalls & Challenges |
|
What are the growth opportunities in this market?
Research and development of new and better veterinary dermatological medications are investments made by the pharmaceutical firms. Improved medicine formulations and modalities of delivery help to increase the efficacy and simplicity of using these drugs.
COVID-19 Impact
The veterinary dermatological medications industry was much changed by the COVID-19 epidemic. Early on in the epidemic, disturbances in world supply systems impacted the availability and distribution of several pharmaceutical items, including veterinary medications. This can have made it difficult to get some veterinary dermatological medications. To further lower the danger of COVID-19 transmission, many veterinary offices also had to use safety precautions including social separation and few in-person visits. This could have changed the frequency of pet visits and consultations, so influencing veterinary dermatology medicine prescriptions..
The epidemic affected pet owner behavior, though; some concentrated more on basic pet care needs and cut non-urgent medical appointments. This can have affected the demand for several veterinary dermatological medications. In certain nations including the United States, the UK, and Germany, pandemic has also resulted in rising pet adoptions and fostering. The market size is increased by this flood of fresh pet owners.
But the market has been seriously disrupted by supply chain interruptions leading to drug shortages and fewer patient visits brought on by lockdowns. As coronavirus cases drop, the market is starting to show regular expansion once more.
Veterinary Dermatology Drugs Market Trends
Several trends were shaping the market includes the growing trend of pet humanization and increased awareness about pet health has led to a higher demand for specialized veterinary dermatology drugs, rising emphasis on preventive care, including dermatological health, increasing investments in research and development to improve drug formulations for veterinary dermatology, rising prevalence of allergies, such as atopic dermatitis, the increasing adoption of telemedicine and e-commerce in veterinary care, and rising adoption of pet insurance. These aforesaid elements are guiding the trends in the market.
Veterinary Dermatology Drugs Market Analysis
Learn more about the key segments shaping this market
Drug class helps to classify the market into antifungal, antibacterial, antiparasitic, and other drug classes. With a 38.0% market share in 2022, the segment of antibacterial medications is largest. Common in animals, especially dogs and cats, bacterial skin diseases are These infections can be brought on by bacteria including Pseudomonas spp., Streptococcus spp., and Staphylococcus spp. Because bacterial skin diseases are so prevalent, veterinary dermatology is highly demanding for efficient antibacterial drugs.
The veterinary dermatology pharmaceuticals market is classified based on indication into parasite infections, autoimmune skin diseases, allergic infections, skin cancer, and other indications. With a 33.3% market share in 2022, the category on parasitic infections is the one largest. Common in animals, parasitic infections can affect skin in a variety of ways including dermatitis, itching, and hair loss. Demand for animal parasiticides arises from the great frequency of parasitic infections.
Learn more about the key segments shaping this market
Veterinarians have three basic choices for treating skin disorders in animalsoral drugs, topical creams, and injections. Of them, oral drugs are likely to be a major player; analysts estimate that they will be valued roughly 3.4 billion US dollars in 2022 and keep increasing by roughly 9.2% annually until 2030. Why are oral medications so often sought for? They can thus enter the bloodstream and go for the underlying source of the skin issue. They're also simple to provide to dogs; just drop a pill into their mouth and you're done! Pets are also more effective over time since they are more inclined to take oral meds regularly.
Imagine thisperhaps a playful puppy or a cosy kitty, you have a furry friend at home. But suppose they begin to scratch and itch like madmen? Veterinary dermatological medications then come in really handy! These medications are like animal magic bullets for skin conditions. Furthermore, as there are several kinds of animals, so are there several kind of dermatology treatments for them. Let's first split our animal buddies in halfOur furry friends that keep us company at home—dogs, cats, even horses—are known as companion animals. Like cows, pigs, and other farm animals, livestock animals are ones we grow for food or other use. Now, suppose which group has been most likely using dermatology medications? You understood the companion animals! Why? Given the growing number of individuals bringing animals into their houses. And we're paying more on their health—including skin treatments—as these animal buddies join our households. Thus, with a huge 60.6% share, companion animals rule the roost in the dermatology drug scene. And they are only going to keep expanding; experts project a shockingly 9.6% increase over the following several years. Just why? Simplewe want our pets to be happy and healthy; skin and all else! We love them.
Hospital pharmacies, retail pharmacies, and online pharmacies classify the veterinary dermatology pharmaceuticals market according on istribution channel. In 2022, the segment of hospital pharmacies with a leading market share of about 56.5% will be To treat many skin problems in animals, including bacterial, fungal, and parasitic diseases, hospital pharmacies carry a large variety of dermatology medications. The availability of these drugs guarantees efficient and quick treatment of dermatological diseases.
Looking for region specific data?
North America veterinary dermatology drugs market accounted for significant revenue in 2022 and is expected to reach USD 6.9 billion in 2032 with a CAGR of 9.3% from 2023-2032. North America has a significant number of veterinary dermatology specialists who focus on diagnosing and treating skin conditions in animals. The availability of specialized care drives the demand for specific dermatology drugs in the region. In addition, the region's strong research and development efforts in veterinary medicine have led to advancements in dermatology drugs. The introduction of new and improved formulations enhances the treatment options available for veterinarians.
Moreover, the trend of pet humanization, where pets are considered part of the family, is increasing in North America. Pet owners are willing to invest in their pets' health and well-being, leading to a higher demand for advanced veterinary dermatology drugs to address skin issues.
Veterinary Dermatology Drugs Market Share
There are several significant competitors in the highly competitive veterinary dermatology drugs companies. The prominent players are
- Elanco Animal Health Incorporated
- Vetoquinol S.A.
- Ceva
- Merck & Co., Inc.
- Zoetis, Inc.
- Virbac
- Bimeda, Inc.
- Vivaldis
- Bioiberica S.A.U
- Indian Immunologicals Ltd.
To keep a competitive advantage in the market, such companies are putting various tactics into practice, including partnerships, mergers, acquisitions, collaborations, and product launches.
Veterinary Dermatology Drugs Market Industry News
- In March 2023, Zoetis announced the addition of two new applications to its Vetscan Imagyst multipurpose diagnostic platformone for AI dermatology and another for AI equine FEC analysis. The Vetscan Imagyst AI dermatology application analysis ear and skin swaps, impression smears, to detect yeast, bacteria, and inflammatory cells providing accurate results.
- In January 2022, Percheron Capital has acquired the majority stake in Animal Dermatology Group, Inc. (ADG), a veterinary dermatology expert in the United States. With this acquisition, ADG's veterinary dermatology specialised services are now available in 12 states throughout the US.
The veterinary dermatology drugs market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD Million from 2018 to 2032 for the following segments
Click here to Buy Section of this Report
Market Size, By Drug Class
- Antibacterial drugs
- Antifungal drugs
- Antiparasitic drugs
- Other drug classes
Market Size, By Indication
- Parasitic infections
- Allergic infections
- Autoimmune skin diseases
- Skin cancer
- Other indications
Market Size, By Route of Administration
- Injectable
- Topical
- Oral
Market Size, By Animal Type
- Companion animal
- Dogs
- Cats
- Horses
- Other companion animals
- Livestock animal
- Bovine
- Swine
- Other livestock animals
Market Size, By Distribution Channel
- Hospital pharmacies
- Retail pharmacies
- Online pharmacies
The above information is provided for the following regions and countries
- North America
- U.S.
- Canada
- Europe
- Germany
- UK
- France
- Spain
- Italy
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Australia
- Rest of Asia Pacific
- Latin America
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
- South Africa
- Saudi Arabia
- Rest of Middle East & Africa
Related Reports
FAQ'S
For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:
Within 24 to 48 hrs.
You can contact Sales team (sales@marketinsightsresearch.com) and they will direct you on email
You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.
Discounts are available.
Hard Copy